REPLY: Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering Drugs

被引：0
|
作者：
Kramer, Caroline K. [1 ]
Ye, Chang [1 ]
Retnakaran, Ravi [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Leadership Sinai Ctr Diabet, 60 Murray St,Suite L5-025,Mailbox 21, Toronto, ON M5T 3L9, Canada
来源：
JACC-HEART FAILURE | 2018年 / 6卷 / 12期
关键词：
D O I：
10.1016/j.jchf.2018.10.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1052 / 1053
页数：2
相关论文
共 50 条
  • [41] Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs
    Alfayez, Osamah M.
    Al Yami, Majed S.
    Alshibani, Mohannad
    Fallatah, Saad B.
    Al Khushaym, Nasser M.
    Alsheikh, Razan
    Alkhatib, Nimer
    PRIMARY CARE DIABETES, 2019, 13 (03) : 204 - 211
  • [42] Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta-analysis of cardiovascular outcome trials of novel glucose-lowering agents
    Kunutsor, Setor K.
    Zaccardi, Francesco
    Balasubramanian, Victoria G.
    Gillies, Clare L.
    Aroda, Vanita R.
    Seidu, Samuel
    Davies, Melanie J.
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2024, 26 (05): : 1837 - 1849
  • [43] Potential of glucose-lowering drugs to reduce cardiovascular events
    Zarich, Stuart W.
    CURRENT DIABETES REPORTS, 2009, 9 (01) : 87 - 94
  • [44] Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials
    Pan, Ssu-Yu
    Su, En-Lin
    Huang, Chi-Jung
    Chuang, Shao-Yuan
    Chiang, Chern-En
    Chen, Chen-Huan
    Cheng, Hao-Min
    AGE AND AGEING, 2024, 53 (08)
  • [45] Potential of glucose-lowering drugs to reduce cardiovascular events
    Stuart W. Zarich
    Current Diabetes Reports, 2009, 9 : 87 - 94
  • [46] Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis
    Shi, Wence
    Zhang, Wenchang
    Zhang, Da
    Ren, Ge
    Wang, Pengfei
    Gao, Lihua
    Chen, Haonan
    Ding, Chunhua
    HEART RHYTHM, 2021, 18 (07) : 1090 - 1096
  • [47] Effects of novel glucose-lowering drugs on the COVID-19 patients with diabetes: A network meta-analysis of clinical outcomes
    Yang, Yang
    Zhao, Ling
    Wang, Yeying
    Liu, Chengjiang
    Ke, Tingyu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (03) : 426 - 436
  • [48] Cardiovascular outcome trials glucose-lowering drugs or strategies in type 2 diabetes (vol 383, pg 2008, 2014)
    Holman, R. R.
    Sourij, H.
    Califf, R. M.
    LANCET, 2014, 383 (9936): : 2212 - 2212
  • [49] Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials
    Lim, Soo
    Oh, Tae Jung
    Dawson, Jesse
    Sattar, Naveed
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 6 - 15
  • [50] Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
    de Carvalho, Luiz Sergio Fernandes
    Nogueira, Ana Claudia Cavalcante
    Bonilha, Isabella
    Luchiari, Beatriz
    Benchimol, Alexander
    Couri, Carlos Eduardo Barra
    Borges, Jairo Lins
    Barreto, Joaquim
    Sposito, Andrei C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345